Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZEJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,122
Award facts
- Contract value 100% obligated
- $20,121.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,121.68 delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injectors, a specialty pharmaceutical product used in the treatment of rheumatoid arthritis and other inflammatory conditions. This firm fixed-price delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a non-set-aside competitive award to the prime contractor's Corporate Office division located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of medical product deliveries. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. This delivery order supports the company's role in fulfilling Defense Health Agency medical procurement requirements within the broader context of the DLA's Pharmaceutical Prime Vendor Global Program, which is transitioning to Generation V contracts with anticipated multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F4ZEJ?
SPE2DR26F4ZEJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F4ZEJ worth?
The government has obligated $20,122 on SPE2DR26F4ZEJ.
Is contract SPE2DR26F4ZEJ an order under another contract?
Yes. SPE2DR26F4ZEJ is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZEJ competed?
The extent of competition for SPE2DR26F4ZEJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award